Triphaladi taila in management of Hypothyroidism

Efficacy of Triphaladi taila in the management of Hypothyroidism- An open labeled randomized control clinical trial - NIL

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/07/070942

Enrollment

Registered

2024-07-22

Start date

Unknown

Completion date

Unknown

Last updated

2024-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E039- Hypothyroidism, unspecified

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Patient who is already taking levothyroxine medicine but having high S.TSH level ,S.TSH greater than 5.5 mIU per L. Newly diagnosed patients of Hypothyroidism with S.TSH greater than 5.5 mIU per L (Sandwich chemi luminescent immuno assay method) (uncontrolled Hypothyroidism) S.Total T3 less than 80 ng per dL S.Total T4 less than 5.0 µg per dL

Exclusion criteria

Exclusion criteria: Patients having any other major systemic diseases like Cancer, Tuberculosis, SLE, etc. Pregnant women or Lactating mothers. Any other debilitating disease which may lead to fatal condition for the patient at any time. Patient having history of peptic ulcers, bleeding ulcers, bleeding piles etc. Patients having any drug abuse. Patients with psychiatric illness Patients taking other medicines for any other acute disease. If S.TSH level is more than 100mIU/L .

Design outcomes

Primary

Measure	Time frame
Management of Hypothyroidism. Role of tailapan in management of Hypothyroidism.Serum total tsh will be assessed before and after trial.Timepoint: 40 days	—

Secondary

Measure	Time frame
To improve quality of lifeTimepoint: 7 days after completion of clinical trial	—

Countries

India

Contacts

Public ContactDr Anamika Soni

Government Akhandanand ayurveda college

ayursoni@yahoo.com9269533108

Outcome results